{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T16:23:35Z","timestamp":1781886215779,"version":"3.54.5"},"reference-count":159,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infection, Genetics and Evolution"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.meegid.2021.104773","type":"journal-article","created":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T12:40:04Z","timestamp":1613565604000},"page":"104773","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":90,"special_numbering":"C","title":["Variants in ACE2; potential influences on virus infection and COVID-19 severity"],"prefix":"10.1016","volume":"90","author":[{"given":"Behnaz","family":"Bakhshandeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shokufeh Ghasemian","family":"Sorboni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir-Reza","family":"Javanmard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Saeed","family":"Mottaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad-reza","family":"Mehrabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzaneh","family":"Sorouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ardeshir","family":"Abbasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohreh","family":"Jahanafrooz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.meegid.2021.104773_bb0005","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3390\/pathogens9050331","article-title":"The human coronavirus disease COVID-19: Its origin, characteristics, and insights into potential drugs and its mechanisms","volume":"9","author":"Alanagreh","year":"2020","journal-title":"Pathogens"},{"key":"10.1016\/j.meegid.2021.104773_bb0010","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s11064-018-2679-4","article-title":"ACE2 in brain physiology and pathophysiology: evidence from transgenic animal models","volume":"44","author":"Alenina","year":"2019","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.meegid.2021.104773_bb0015","article-title":"ACE2 coding variants in different populations and their potential impact on SARS-CoV-2 binding affinity","volume":"24","author":"Ali","year":"2020","journal-title":"Biochem. Biophys. Rep."},{"key":"10.1016\/j.meegid.2021.104773_bb0020","series-title":"Repurposing Naproxen as a Potential Antiviral Agent Against SARS-CoV-2","author":"Alizadeh-Navaei","year":"2020"},{"key":"10.1016\/j.meegid.2021.104773_bb0025","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1093\/ndt\/gfv025","article-title":"Circulating angiotensin-converting enzyme 2 activity in patients with chronic kidney disease without previous history of cardiovascular disease","volume":"30","author":"Anguiano","year":"2015","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.meegid.2021.104773_bb0030","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jmv.20288","article-title":"New human coronavirus, HCoV-NL63, associated with severe lower respiratory tract disease in Australia","volume":"75","author":"Arden","year":"2005","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.meegid.2021.104773_bb0040","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1038\/s41431-020-0691-z","article-title":"ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population","volume":"28","author":"Benetti","year":"2020","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.meegid.2021.104773_bb0045","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1038\/s41431-020-0691-z","article-title":"ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population","volume":"28","author":"Benetti","year":"2020","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.meegid.2021.104773_bb0050","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrneph.2018.15","article-title":"Angiotensin-converting enzyme in innate and adaptive immunity","volume":"14","author":"Bernstein","year":"2018","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.meegid.2021.104773_bb0055","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrneph.2018.15","article-title":"Angiotensin-converting enzyme in innate and adaptive immunity","volume":"14","author":"Bernstein","year":"2018","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.meegid.2021.104773_bb0060","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1165\/rcmb.2011-0392TR","article-title":"Role of chemokines in the pathogenesis of acute lung injury","volume":"46","author":"Bhatia","year":"2012","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.meegid.2021.104773_bb0065","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/jmv.23865","article-title":"Effect of the IL28B Rs12979860 C\/T polymorphism on the incidence and features of active cytomegalovirus infection in allogeneic stem cell transplant patients","volume":"86","author":"Bravo","year":"2014","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.meegid.2021.104773_bb0070","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.biochi.2020.11.004","article-title":"Molecular docking simulation reveals ACE2 polymorphisms that may increase the affinity of ACE2 with the SARS-CoV-2 Spike protein","volume":"180","author":"Calcagnile","year":"2021","journal-title":"Biochimie"},{"key":"10.1016\/j.meegid.2021.104773_bb0075","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1053\/j.gastro.2008.10.055","article-title":"Tissue-Specific Amino Acid Transporter Partners ACE2 and Collectrin Differentially Interact With Hartnup Mutations","volume":"e873","author":"Camargo","year":"2009","journal-title":"Gastroenterology 136"},{"key":"10.1016\/j.meegid.2021.104773_bb0080","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.virusres.2007.02.014","article-title":"Human immunopathogenesis of severe acute respiratory syndrome (SARS)","volume":"133","author":"Cameron","year":"2008","journal-title":"Virus Res."},{"key":"10.1016\/j.meegid.2021.104773_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41421-020-0147-1","article-title":"Comparative genetic analysis of the novel coronavirus (2019-nCoV\/SARS-CoV-2) receptor ACE2 in different populations","volume":"6","author":"Cao","year":"2020","journal-title":"Cell Discov."},{"key":"10.1016\/j.meegid.2021.104773_bb0090","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/22221751.2020.1719902","article-title":"Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan","volume":"9","author":"Chan","year":"2020","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.meegid.2021.104773_bb0095","series-title":"Pathogenic Human Coronavirus Infections: Causes and Consequences of Cytokine Storm and Immunopathology, Seminars in Immunopathology","first-page":"529","author":"Channappanavar","year":"2017"},{"key":"10.1016\/j.meegid.2021.104773_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s43042-020-00099-9","article-title":"COVID-19 susceptibility: potential of ACE2 polymorphisms","volume":"21","author":"Chaudhary","year":"2020","journal-title":"Egypt. J. Med. Human Genet."},{"key":"10.1016\/j.meegid.2021.104773_bb0105","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1128\/JCM.44.2.359-365.2006","article-title":"Epidemiological and genetic correlates of severe acute respiratory syndrome coronavirus infection in the hospital with the highest nosocomial infection rate in Taiwan in 2003","volume":"44","author":"Chen","year":"2006","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.meegid.2021.104773_bb0110","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1073\/pnas.0808790106","article-title":"Functional screen reveals SARS coronavirus nonstructural protein nsp14 as a novel cap N7 methyltransferase","volume":"106","author":"Chen","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.meegid.2021.104773_bb0115","series-title":"First clinical study using HCV protease inhibitor danoprevir to treat naive and experienced COVID-19 patients","author":"Chen","year":"2020"},{"key":"10.1016\/j.meegid.2021.104773_bb0120","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.meegid.2021.104773_bb0125","series-title":"Coronavirus disease-19: The First 7,755 Cases in the Republic of Korea. medRxiv","author":"Choe","year":"2020"},{"key":"10.1016\/j.meegid.2021.104773_bb0130","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/acem.14005","article-title":"A Rapid systematic review of clinical trials utilizing chloroquine and hydroxychloroquine as a treatment for COVID-19","volume":"27","author":"Chowdhury","year":"2020","journal-title":"Acad. Emerg. Med."},{"key":"10.1016\/j.meegid.2021.104773_bb0135","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cytogfr.2020.05.003","article-title":"The Cytokine storm in COVID-19: an overview of the involvement of the chemokine\/chemokine-receptor system","volume":"53","author":"Coperchini","year":"2020","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.meegid.2021.104773_bb0140","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jcrc.2020.03.005","article-title":"A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19","volume":"57","author":"Cortegiani","year":"2020","journal-title":"J. Crit. Care"},{"key":"10.1016\/j.meegid.2021.104773_bb0145","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nature00786","article-title":"Angiotensin-converting enzyme 2 is an essential regulator of heart function","volume":"417","author":"Crackower","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.meegid.2021.104773_bb0150","series-title":"Variants in ACE2 and TMPRSS2 genes are not major determinants of COVID-19 severity in UK Biobank subjects. medRxiv preprint","author":"Curtis","year":"2020"},{"key":"10.1016\/j.meegid.2021.104773_bb0155","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nature09489","article-title":"2\u2032-O methylation of the viral mRNA cap evades host restriction by IFIT family members","volume":"468","author":"Daffis","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.meegid.2021.104773_bb0160","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/nature05475","article-title":"Essential role for collectrin in renal amino acid transport","volume":"444","author":"Danilczyk","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.meegid.2021.104773_bb0165","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/0022-2836(87)90422-0","article-title":"Evidence for a coiled-coil structure in the spike proteins of coronaviruses","volume":"196","author":"De Groot","year":"1987","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.meegid.2021.104773_bb0170","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijid.2020.05.085","article-title":"Lack of antiviral activity of darunavir against SARS-CoV-2","volume":"97","author":"De Meyer","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.meegid.2021.104773_bb0175","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jmii.2020.04.015","article-title":"ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome","volume":"53","author":"Devaux","year":"2020","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"10.1016\/j.meegid.2021.104773_bb0180","first-page":"4040","article-title":"Eculizumab treatment in patients with COVID-19: preliminary results from real life ASL Napoli 2 Nord experience","volume":"24","author":"Diurno","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.meegid.2021.104773_bb0185","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/01.RES.87.5.e1","article-title":"A novel angiotensin-converting enzyme\u2013related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9","volume":"87","author":"Donoghue","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.meegid.2021.104773_bb0190","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1161\/01.RES.87.5.e1","article-title":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9","volume":"87","author":"Donoghue","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.meegid.2021.104773_bb0195","series-title":"Lopinavir\/ritonavir: A rapid review of effectiveness in COVID-19","author":"Dorward","year":"2020"},{"key":"10.1016\/j.meegid.2021.104773_bb0200","article-title":"The trial of chloroquine in the treatment of Corona virus disease 2019 (COVID-19) and its research progress in forensic toxicology","volume":"36","author":"Duan","year":"2020","journal-title":"Fa yi xue za zhi"},{"key":"10.1016\/j.meegid.2021.104773_bb0205","series-title":"High-dose intravenous vitamin C treatment for COVID-19","author":"Erol","year":"2020"},{"key":"10.1016\/j.meegid.2021.104773_bb0210","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1074\/mcp.M113.035600","article-title":"Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics","volume":"13","author":"Fagerberg","year":"2014","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.meegid.2021.104773_bb0215","article-title":"Severe COVID-19 infection in a patient with multiple sclerosis treated with fingolimod","volume":"102180","author":"Foerch","year":"2020","journal-title":"Mult. Sclerosis Related Disord."},{"key":"10.1016\/j.meegid.2021.104773_bb0220","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00109-012-0894-z","article-title":"Emergence and evolution of the renin-angiotensin-aldosterone system","volume":"90","author":"Fournier","year":"2012","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.meegid.2021.104773_bb0225","doi-asserted-by":"crossref","first-page":"6631","DOI":"10.1128\/JVI.00367-09","article-title":"Molecular determinants for subcellular localization of the severe acute respiratory syndrome coronavirus open reading frame 3b protein","volume":"83","author":"Freundt","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2021.104773_bb0230","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/978-1-4615-1325-4_30","article-title":"Murine coronavirus spike glycoprotein: Receptor binding and membrane fusion activities","author":"Gallagher","year":"2001","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.meegid.2021.104773_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.anpede.2020.04.006","article-title":"Narrative review of the immune response against coronavirus: an overview, applicability for SARS-COV-2, and therapeutic implications","volume":"93","author":"Garc\u00eda-Salido","year":"2020","journal-title":"Anales de Pediatr\u00eda (English Edition)"},{"key":"10.1016\/j.meegid.2021.104773_bb0240","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S2213-2600(20)30225-3","article-title":"Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy","volume":"8","author":"George","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.meegid.2021.104773_bb0245","series-title":"Nitric oxide gas inhalation to prevent COVID-2019 in healthcare providers. medRxiv","author":"Gianni","year":"2020"},{"key":"10.1016\/j.meegid.2021.104773_bb0250","article-title":"ACE 2 Coding Variants: A Potential X-linked Risk Factor 1 for COVID-19 Disease","volume":"2020","author":"Gibson","year":"2020","journal-title":"bioRxiv preprint"},{"key":"10.1016\/j.meegid.2021.104773_bb0255","first-page":"1","article-title":"Mesenchymal stem cell therapy for COVID-19: present or future","author":"Golchin","year":"2020","journal-title":"Stem Cell Rev. Rep."},{"key":"10.1016\/j.meegid.2021.104773_bb0260","series-title":"Sarilumab use in severe SARS-CoV-2 pneumonia. medRxiv","author":"Gremese","year":"2020"},{"key":"10.1016\/j.meegid.2021.104773_bb0265","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1084\/jem.20050828","article-title":"Multiple organ infection and the pathogenesis of SARS","volume":"202","author":"Gu","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.meegid.2021.104773_bb0270","volume":"9","author":"Guo","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.meegid.2021.104773_bb0275","series-title":"Investigation of the genetic variation in ACE2 on the structural recognition by the novel coronavirus (SARS-CoV-2)","author":"Guo","year":"2020"},{"key":"10.1016\/j.meegid.2021.104773_bb0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-020-02486-7","article-title":"Investigation of the genetic variation in ACE2 on the structural recognition by the novel coronavirus (SARS-CoV-2)","volume":"18","author":"Guo","year":"2020","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.meegid.2021.104773_bb0285","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/ddr.21656","article-title":"Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics","volume":"81","author":"Gurwitz","year":"2020","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.meegid.2021.104773_bb0290","doi-asserted-by":"crossref","first-page":"13185","DOI":"10.1021\/bi035268s","article-title":"Angiotensin-converting enzyme-2 (ACE2): comparative modelling of the active site, substrate specificity and chloride sensitivity","volume":"42","author":"Guy","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.meegid.2021.104773_bb0295","doi-asserted-by":"crossref","first-page":"13185","DOI":"10.1021\/bi035268s","article-title":"Angiotensin-converting enzyme-2 (ACE2): comparative modeling of the active site, specificity requirements, and chloride dependence","volume":"42","author":"Guy","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.meegid.2021.104773_bb0300","doi-asserted-by":"crossref","first-page":"104853","DOI":"10.1016\/j.phrs.2020.104853","article-title":"Possible use of the mucolytic drug, bromhexine hydrochloride, as a prophylactic agent against SARS-CoV-2 infection based on its action on the Transmembrane Serine Protease 2","volume":"157","author":"Habtemariam","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.meegid.2021.104773_bb0305","doi-asserted-by":"crossref","first-page":"211","DOI":"10.4103\/1817-1737.185756","article-title":"Association of human leukocyte antigen class II alleles with severe Middle East respiratory syndrome-coronavirus infection","volume":"11","author":"Hajeer","year":"2016","journal-title":"Ann. Thorac. Med."},{"key":"10.1016\/j.meegid.2021.104773_bb0310","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/nature11228","article-title":"ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation","volume":"487","author":"Hashimoto","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.meegid.2021.104773_bb0315","doi-asserted-by":"crossref","first-page":"7988","DOI":"10.1073\/pnas.0409465102","article-title":"Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry","volume":"102","author":"Hofmann","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.meegid.2021.104773_bb0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-020-01673-z","article-title":"New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis","volume":"18","author":"Hou","year":"2020","journal-title":"BMC Med."},{"key":"10.1016\/j.meegid.2021.104773_bb0325","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s12916-020-01673-z","article-title":"New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis","volume":"18","author":"Hou","year":"2020","journal-title":"BMC Med."},{"key":"10.1016\/j.meegid.2021.104773_bb0330","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/jmv.26232","article-title":"The cytokine storm and COVID-19","volume":"93","author":"Hu","year":"2021","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.meegid.2021.104773_bb0335","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.meegid.2021.104773_bb0340","doi-asserted-by":"crossref","first-page":"e393","DOI":"10.1016\/S2665-9913(20)30164-8","article-title":"Anakinra for severe forms of COVID-19: a cohort study","volume":"2","author":"Huet","year":"2020","journal-title":"Lancet Rheumatol."},{"key":"10.1016\/j.meegid.2021.104773_bb0345","series-title":"Structural basis of SARS-CoV-2 spike protein priming by TMPRSS2","author":"Hussain","year":"2020"},{"key":"10.1016\/j.meegid.2021.104773_bb0350","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nature03712","article-title":"Angiotensin-converting enzyme 2 protects from severe acute lung failure","volume":"436","author":"Imai","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.meegid.2021.104773_bb0355","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010301","article-title":"Identification and disruption of sperm-specific angiotensin converting enzyme-3 (ACE3) in mouse","volume":"5","author":"Inoue","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.meegid.2021.104773_bb0360","doi-asserted-by":"crossref","first-page":"15748","DOI":"10.1073\/pnas.0403812101","article-title":"CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus","volume":"101","author":"Jeffers","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.meegid.2021.104773_bb0365","article-title":"The impact of ACE2 gene polymorphism in the development of COVID-19 disease","volume":"31","author":"Karahalil","year":"2020","journal-title":"Gazi Med. J."},{"key":"10.1016\/j.meegid.2021.104773_bb0370","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000503030","article-title":"Innate Immune Evasion by Human Respiratory RNA Viruses","volume":"12","author":"Kikkert","year":"2020","journal-title":"J. Innate Immun."},{"key":"10.1016\/j.meegid.2021.104773_bb0375","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1007\/s00018-018-2815-y","article-title":"Depletion of angiotensin-converting enzyme 2 reduces brain serotonin and impairs the running-induced neurogenic response","volume":"75","author":"Klempin","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.meegid.2021.104773_bb0380","series-title":"The deubiquitinating activity of Middle East respiratory syndrome coronavirus papain-like protease delays the innate immune response and enhances virulence in a mouse model. bioRxiv","first-page":"751578","author":"Knaap","year":"2019"},{"key":"10.1016\/j.meegid.2021.104773_bb0385","first-page":"217","article-title":"Molecular cloning, mRNA expression and chromosomal localization of mouse angiotensin-converting enzyme-related carboxypeptidase (mACE2)","volume":"13","author":"Komatsu","year":"2002","journal-title":"Mitochondrial DNA"},{"key":"10.1016\/j.meegid.2021.104773_bb0390","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1007\/s00018-004-4242-5","article-title":"Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus","volume":"61","author":"Kuhn","year":"2004","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.meegid.2021.104773_bb0395","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.antiviral.2013.08.014","article-title":"Receptor recognition and cross-species infections of SARS coronavirus","volume":"100","author":"Li","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.meegid.2021.104773_bb0400","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.meegid.2021.104773_bb0405","doi-asserted-by":"crossref","first-page":"11429","DOI":"10.1128\/JVI.78.20.11429-11433.2004","article-title":"Efficient replication of severe acute respiratory syndrome coronavirus in mouse cells is limited by murine angiotensin-converting enzyme 2","volume":"78","author":"Li","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2021.104773_bb0410","doi-asserted-by":"crossref","first-page":"4211","DOI":"10.1128\/JVI.80.9.4211-4219.2006","article-title":"Animal origins of the severe acute respiratory syndrome coronavirus: insight from ACE2-S-protein interactions","volume":"80","author":"Li","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2021.104773_bb0415","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.3201\/eid2606.200287","article-title":"Lack of vertical transmission of severe acute respiratory syndrome coronavirus 2, China","volume":"26","author":"Li","year":"2020","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.meegid.2021.104773_bb0420","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1515\/cclm-2020-0727","article-title":"Do genetic polymorphisms in angiotensin converting enzyme 2 (ACE2) gene play a role in coronavirus disease 2019 (COVID-19)?","volume":"58","author":"Lippi","year":"2020","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.meegid.2021.104773_bb0425","article-title":"Do genetic polymorphisms in angiotensin converting enzyme 2 (ACE2) gene play a role in coronavirus disease 2019 (COVID-19)?","volume":"1","author":"Lippi","year":"2020","journal-title":"Clin. Chem. Lab. Med. (CCLM)"},{"key":"10.1016\/j.meegid.2021.104773_bb0430","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1002\/jmv.25860","article-title":"Clinical and demographic characteristics of patients dying from COVID-19 in Italy vs China","volume":"92","author":"Lippi","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.meegid.2021.104773_bb0435","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1126\/science.1086616","article-title":"Transmission dynamics and control of severe acute respiratory syndrome","volume":"300","author":"Lipsitch","year":"2003","journal-title":"science"},{"key":"10.1016\/j.meegid.2021.104773_bb0440","doi-asserted-by":"crossref","first-page":"11849","DOI":"10.1128\/JVI.01464-10","article-title":"Novel immunodominant peptide presentation strategy: a featured HLA-A* 2402-restricted cytotoxic T-lymphocyte epitope stabilized by intrachain hydrogen bonds from severe acute respiratory syndrome coronavirus nucleocapsid protein","volume":"84","author":"Liu","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2021.104773_bb0445","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/rth2.12353","article-title":"Using heparin molecules to manage COVID-2019","volume":"4","author":"Liu","year":"2020","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.meegid.2021.104773_bb0450","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1002\/jmv.26033","article-title":"Baricitinib: a chance to treat COVID-19?","volume":"92","author":"Lo Caputo","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.meegid.2021.104773_bb0455","series-title":"SARS-CoV-2 sensitive to type I interferon pretreatment","author":"Lokugamage","year":"2020"},{"key":"10.1016\/j.meegid.2021.104773_bb0460","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.meegid.2021.104773_bb0465","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1002\/jmv.25817","article-title":"SARS-CoV-2 spike protein favors ACE2 from Bovidae and Cricetidae","volume":"92","author":"Luan","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.meegid.2021.104773_bb0470","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/jmv.25801","article-title":"Tocilizumab treatment in COVID-19: A single center experience","volume":"92","author":"Luo","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.meegid.2021.104773_bb0475","article-title":"Missense variants in ACE2 are predicted to encourage and inhibit interaction with SARS-CoV-2 Spike and contribute to genetic risk in COVID-19","author":"MacGowan","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.meegid.2021.104773_bb0480","first-page":"807","article-title":"Focus on receptors for coronaviruses with special reference to angiotensin-converting enzyme 2 as a potential drug target-a perspective","volume":"20","author":"Magrone","year":"2020","journal-title":"Endocr Metab Immune Disord Drug Targets (Formerly Current Drug Targets-Immune, Endocrine & Metabolic Disorders)"},{"key":"10.1016\/j.meegid.2021.104773_bb0490","article-title":"Antiviral activities of type I interferons to SARS-CoV-2 infection","volume":"104811","author":"Mantlo","year":"2020","journal-title":"Antivir. Res."},{"key":"10.1016\/j.meegid.2021.104773_bb0495","article-title":"Pathogenesis of COVID-19 from a cell biology perspective","volume":"55","author":"Mason","year":"2020","journal-title":"Eur Respiratory Soc"},{"key":"10.1016\/j.meegid.2021.104773_bb0505","doi-asserted-by":"crossref","first-page":"961","DOI":"10.3390\/v11100961","article-title":"Viral innate immune evasion and the pathogenesis of emerging RNA virus infections","volume":"11","author":"Nelemans","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.meegid.2021.104773_bb0510","doi-asserted-by":"crossref","first-page":"104378","DOI":"10.1016\/j.jcv.2020.104378","article-title":"Epidemiological characteristics of coronavirus disease 2019 (COVID-19) patients in IRAN: a single center study","volume":"127","author":"Nikpouraghdam","year":"2020","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.meegid.2021.104773_bb0515","first-page":"145","article-title":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China","volume":"41","author":"Novel","year":"2020","journal-title":"Zhonghua liu xing bing xue za zhi= Zhonghua liuxingbingxue zazhi"},{"key":"10.1016\/j.meegid.2021.104773_bb0520","series-title":"Coronavirus disease 2019 (COVID-19) Situation Report-63","author":"Organization., W.H","year":"2020"},{"key":"10.1016\/j.meegid.2021.104773_bb0525","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/ejhpharm-2020-002322","article-title":"Involvement of interleukin 6 in SARS-CoV-2 infection: siltuximab as a therapeutic option against COVID-19","volume":"27","author":"Palanques-Pastor","year":"2020","journal-title":"Eur. J. Hosp. Pharm."},{"key":"10.1016\/j.meegid.2021.104773_bb0530","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1038\/nm1143","article-title":"Severe acute respiratory syndrome","volume":"10","author":"Peiris","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.meegid.2021.104773_bb0535","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1038\/nm1143","article-title":"Severe acute respiratory syndrome","volume":"10","author":"Peiris","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.meegid.2021.104773_bb0540","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nrmicro2147","article-title":"Coronaviruses post-SARS: update on replication and pathogenesis","volume":"7","author":"Perlman","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.meegid.2021.104773_bb0545","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa030634","article-title":"Identification of severe acute respiratory syndrome in Canada","volume":"348","author":"Poutanen","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.meegid.2021.104773_bb0550","article-title":"The sequence of human ACE2 is suboptimal for binding the S spike protein of SARS coronavirus 2","author":"Procko","year":"2020","journal-title":"BioRxiv"},{"key":"10.1016\/j.meegid.2021.104773_bb0555","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S1473-3099(20)30198-5","article-title":"Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study","volume":"20","author":"Qiu","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.meegid.2021.104773_bb0560","first-page":"174","article-title":"SARS-CoV-2, SARS-CoV, and MERS-CoV: a comparative overview","volume":"28","author":"Rabaan","year":"2020","journal-title":"Infez Med"},{"key":"10.1016\/j.meegid.2021.104773_bb0565","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104429","article-title":"Measurement of oxidized albumin: An opportunity for diagnoses or treatment of COVID-19","volume":"105","author":"Rahmani-Kukia","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.meegid.2021.104773_bb0570","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1042\/BJ20040634","article-title":"Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism","volume":"383","author":"Rice","year":"2004","journal-title":"Biochem. J."},{"key":"10.1016\/j.meegid.2021.104773_bb0575","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1126\/science.1086478","article-title":"Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions","volume":"300","author":"Riley","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.meegid.2021.104773_bb0580","article-title":"Convalescent plasma in Covid-19: Possible mechanisms of action","volume":"102554","author":"Rojas","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.meegid.2021.104773_bb0585","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.arcmed.2020.05.001","article-title":"Probable molecular mechanism of remdesivir for the treatment of COVID-19: need to know more","volume":"51","author":"Saha","year":"2020","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.meegid.2021.104773_bb0590","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/cvr\/cvt245","article-title":"Deletion of angiotensin-converti enzyme 2 promotes the development of atherosclerosis and arterial neointima formation","volume":"101","author":"Sahara","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.meegid.2021.104773_bb0595","first-page":"11","article-title":"Novel Coronavirus-induced NLRP3 inflammasome activation: a potential drug target in the treatment of COVID-19","author":"Shah","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.meegid.2021.104773_bb0600","series-title":"Favipiravir strikes the SARS-CoV-2 at its Achilles heel, the RNA polymerase. bioRxiv","author":"Shannon","year":"2020"},{"key":"10.1016\/j.meegid.2021.104773_bb0605","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2020.551220","article-title":"Analysis of the spectrum of ACE2 variation suggests a possible influence of rare and common variants on susceptibility to COVID-19 and severity of outcome","volume":"11","author":"Shikov","year":"2020","journal-title":"Front. Genet."},{"key":"10.1016\/j.meegid.2021.104773_bb0610","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1073\/pnas.0306446101","article-title":"Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry","volume":"101","author":"Simmons","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.meegid.2021.104773_bb0615","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1099\/0022-1317-69-12-2939","article-title":"Coronaviruses: structure and genome expression","volume":"69","author":"Spaan","year":"1988","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.meegid.2021.104773_bb0620","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.bbrc.2003.08.122","article-title":"Molecular modelling of S1 and S2 subunits of SARS coronavirus spike glycoprotein","volume":"310","author":"Spiga","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.meegid.2021.104773_bb0625","series-title":"Human ACE2 receptor polymorphisms predict SARS-CoV-2 susceptibility","author":"Stawiski","year":"2020"},{"key":"10.1016\/j.meegid.2021.104773_bb0630","series-title":"bioRxiv 024752","article-title":"Human ACE2 receptor polymorphisms predict SARS-CoV-2 susceptibility","author":"Stawiski","year":"2020"},{"key":"10.1016\/j.meegid.2021.104773_bb0635","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00426-20","article-title":"Ca2+ ions promote fusion of Middle East respiratory syndrome coronavirus with host cells and increase infectivity","volume":"94","author":"Straus","year":"2020","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2021.104773_bb0640","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1073\/pnas.0307140101","article-title":"Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association","volume":"101","author":"Sui","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.meegid.2021.104773_bb0645","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.580641","article-title":"Covid-19: perspectives on innate immune evasion","volume":"11","author":"Taefehshokr","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.meegid.2021.104773_bb0650","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1161\/01.HYP.0000060689.38912.CB","article-title":"Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy","volume":"41","author":"Tikellis","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.meegid.2021.104773_bb0655","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1161\/01.HYP.0000060689.38912.CB","article-title":"Characterization of renal angiotensin - converting enzyme 2 in diabetic nephropathy","volume":"41","author":"Tikellis","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.meegid.2021.104773_bb0660","doi-asserted-by":"crossref","first-page":"33238","DOI":"10.1074\/jbc.M002615200","article-title":"A human homolog of angiotensin-converting enzyme: cloning and functional expression as a captopril-insensitive carboxypeptidase","volume":"275","author":"Tipnis","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.meegid.2021.104773_bb0665","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.coviro.2012.04.004","article-title":"SARS coronavirus pathogenesis: host innate immune responses and viral antagonism of interferon","volume":"2","author":"Totura","year":"2012","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.meegid.2021.104773_bb0670","first-page":"101","article-title":"Functional polymorphisms of the CCL2 and MBL genes cumulatively increase susceptibility to severe acute respiratory syndrome coronavirus infection","volume":"71","author":"Tu","year":"2015","journal-title":"J. Inf. Secur."},{"key":"10.1016\/j.meegid.2021.104773_bb0675","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.3390\/ijms21072657","article-title":"A review of SARS-CoV-2 and the ongoing clinical trials","volume":"21","author":"Tu","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.meegid.2021.104773_bb0680","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0165-6147(00)01994-5","article-title":"The angiotensin\u2013converting enzyme gene family: genomics and pharmacology","volume":"23","author":"Turner","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.meegid.2021.104773_bb0685","first-page":"1","article-title":"Camostat mesilate therapy for COVID-19","author":"Uno","year":"2020","journal-title":"Intern. Emerg. Med."},{"key":"10.1016\/j.meegid.2021.104773_bb0690","series-title":"Successful treatment of Severe COVID-19 Pneumonia with Clazakizumab in a Heart Transplant Recipient: Case Report, Transplantation Proceedings","author":"Vaidya","year":"2020"},{"key":"10.1016\/j.meegid.2021.104773_bb0695","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nm1024","article-title":"Identification of a new human coronavirus","volume":"10","author":"Van Der Hoek","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.meegid.2021.104773_bb0700","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1574-6976.2006.00032.x","article-title":"Human coronavirus NL63, a new respiratory virus","volume":"30","author":"Van Der Hoek","year":"2006","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.meegid.2021.104773_bb0705","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.omtm.2019.06.007","article-title":"Expression of Human ACE2 in Lactobacillus and Beneficial Effects in Diabetic Retinopathy in Mice","volume":"14","author":"Verma","year":"2019","journal-title":"Mol. Ther. - Methods Clin. Dev."},{"key":"10.1016\/j.meegid.2021.104773_bb0710","doi-asserted-by":"crossref","first-page":"14838","DOI":"10.1074\/jbc.M200581200","article-title":"Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase","volume":"277","author":"Vickers","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.meegid.2021.104773_bb0715","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1089\/vim.2011.0024","article-title":"Human-leukocyte antigen class I Cw 1502 and class II DR 0301 genotypes are associated with resistance to severe acute respiratory syndrome (SARS) infection","volume":"24","author":"Wang","year":"2011","journal-title":"Viral Immunol."},{"key":"10.1016\/j.meegid.2021.104773_bb0720","doi-asserted-by":"crossref","DOI":"10.1038\/npjamd.2016.24","article-title":"Deficiency of angiotensin-converting enzyme 2 causes deterioration of cognitive function","volume":"2","author":"Wang","year":"2016","journal-title":"npj Aging Mech. Dis."},{"key":"10.1016\/j.meegid.2021.104773_bb0725","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41421-020-0169-8","article-title":"The anti-influenza virus drug, arbidol is an efficient inhibitor of SARS-CoV-2 in vitro","volume":"6","author":"Wang","year":"2020","journal-title":"Cell Discov."},{"key":"10.1016\/j.meegid.2021.104773_bb0730","series-title":"Coronavirus disease (COVID-19) Situation Report\u2013134","author":"WHO","year":"2020"},{"key":"10.1016\/j.meegid.2021.104773_bb0735","first-page":"L217","article-title":"The mercurial nature of neutrophils: still an enigma in ARDS?","volume":"306","author":"Williams","year":"2014","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"key":"10.1016\/j.meegid.2021.104773_bb0740","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1074\/jbc.C300520200","article-title":"A 193-amino acid fragment of the SARS Coronavirus S protein efficiently binds angiotensin-converting enzyme 2","volume":"279","author":"Wong","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.meegid.2021.104773_bb0745","series-title":"Polymorphisms in the ACE2 Locus Associate with Severity of COVID-19 Infection. medRxiv preprint","author":"Wooster","year":"2020"},{"key":"10.1016\/j.meegid.2021.104773_bb0750","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.meegid.2021.104773_bb0755","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.chom.2020.02.001","article-title":"Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China","volume":"27","author":"Wu","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.meegid.2021.104773_bb0760","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1161\/CIRCRESAHA.113.301811","article-title":"Brain angiotensin-converting enzyme type 2 shedding contributes to the development of neurogenic hypertension","volume":"113","author":"Xia","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.meegid.2021.104773_bb0765","first-page":"318","article-title":"Effect of regular intravenous immunoglobulin therapy on prognosis of severe pneumonia in patients with COVID-19","volume":"81","author":"Xie","year":"2020","journal-title":"J. Inf. Secur."},{"key":"10.1016\/j.meegid.2021.104773_bb0770","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s11427-020-1637-5","article-title":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission","volume":"63","author":"Xu","year":"2020","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.meegid.2021.104773_bb0775","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.meegid.2021.104773_bb0780","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/357420a0","article-title":"Human aminopeptidase N is a receptor for human coronavirus 229E","volume":"357","author":"Yeager","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.meegid.2021.104773_bb0785","article-title":"The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality","volume":"105954","author":"Zhang","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.meegid.2021.104773_bb0790","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.cub.2020.03.063","article-title":"Probable pangolin origin of SARS-CoV-2 associated with the COVID-19 outbreak","volume":"30","author":"Zhang","year":"2020","journal-title":"Curr. Biol."},{"key":"10.1016\/j.meegid.2021.104773_bb0795","article-title":"Broad and differential animal ACE2 receptor usage by SARS-CoV-2","volume":"94","author":"Zhao","year":"2020","journal-title":"J. Virol. JVI."},{"key":"10.1016\/j.meegid.2021.104773_bb0800","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S0140-6736(03)14630-2","article-title":"Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People\u2019s Republic of China, in February, 2003","volume":"362","author":"Zhong","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.meegid.2021.104773_bb0805","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.meegid.2021.104773_bb0810","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1056\/NEJMc2001737","article-title":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients","volume":"382","author":"Zou","year":"2020","journal-title":"N. Engl. J. Med."}],"container-title":["Infection, Genetics and Evolution"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567134821000708?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567134821000708?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T14:49:28Z","timestamp":1761576568000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567134821000708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":159,"alternative-id":["S1567134821000708"],"URL":"https:\/\/doi.org\/10.1016\/j.meegid.2021.104773","relation":{},"ISSN":["1567-1348"],"issn-type":[{"value":"1567-1348","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Variants in ACE2; potential influences on virus infection and COVID-19 severity","name":"articletitle","label":"Article Title"},{"value":"Infection, Genetics and Evolution","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.meegid.2021.104773","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104773"}}